Since the first, seminal randomised controlled trial (RCT) in inflammatory bowel disease (IBD) in 1955,1 the central tenets for high-quality clinical trials have been recognised as robust and ...

The partnership will integrate PhaseV's adaptive clinical trial technology with Alimentiv's comprehensive GI CRO services.

People living with inflammatory bowel disease (IBD) have new hope, with clinical trials beginning for a breakthrough treatment for one of the most ...

Researchers from The Institute of Cancer Research in London have developed a new test that can predict colorectal cancer risk ...

PhaseV, a pioneer in software and machine learning (ML) for clinical trial optimization, announced today it has entered a ...

Gastrointestinal-focused CRO Alimentiv is upgrading its clinical trials with software firm PhaseV’s adaptive trial technology ...

Inflammatory bowel diseases (IBDs), which include ulcerative colitis (UC) and Crohn’s disease (CD), are chronic conditions ...

Eli Lilly And Cao (NYSE:LLY) announced the results from the VIVID-2 open-label extension study of Omvoh (mirikizumab-mrkz).

A groundbreaking test can now predict colorectal cancer risk in IBD patients with over 90 accuracy offering a less invasive ...

The Crohn’s & Colitis Foundation and the American Gastroenterological Association (AGA) are excited to host the annual Crohn’s & Colitis Congress®, taking place Feb. 6-8, in San Francisco, CA. This ...

Most vegetables are good for your health and help prevent inflammation. However, some vegetables, like nightshades, can ...

Major Cause of Inflammatory Bowel Disease Discovered June 5 ... 2024 — A large-scale clinical trial of treatment strategies for Crohn's disease has shown that offering early advanced therapy ...